Role of pelvic lymphadenectomy in the management of Stage I endometrial cancer: Our experience

E. Vizza, G. M. Galati, G. Corrado, C. Sbiroli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: To estimate the prognostic value of pelvic-node removal on survival of patients affected by endometrial carcinoma at presurgical FIGO Stage I. Methods: A retrospective analysis was performed on a total of 111 patients recruited from 1990 to 1996 at the S. Carlo di Nancy Hospital. Thirty-nine (35%) of them underwent a total hysterectomy and bilateral salpingo-oophorectomy with removal of the vaginal cuff (group 1), while 72 (65%) underwent a total hysterectomy combined with pelvic lymphadenectomy (group 2). Prognostic features including tumor grade, depth of myometrial invasion and histologic subtype. Survival rates were calculated with Cox and Kaplan analyses. Results: Overall survival rate at five years was 91.2%. The survival rate of group 1 and group 2 was 89% and 92.8%, respectively which is not statistically significant. Stage, grade, histotype, age at diagnosis, and presence of positive lymph nodes did not show any significant prognostic value on survival probability. Conclusions: The survival rate for patients submitted to lymphadenectomy (group 2) was the same of patients who did not undergo this treatment (group 1). Nevertheless, pelvic lymphadenectomy in endometrial carcinoma at presurgical FIGO stage I was worthwhile as it allowed correct staging to be performed. The prediction of nodal disease based only on preoperative investigations (such as TC, NMR) is often inaccurate.

Original languageEnglish
Pages (from-to)126-128
Number of pages3
JournalEuropean Journal of Gynaecological Oncology
Volume24
Issue number2
Publication statusPublished - 2003

Fingerprint

Endometrial Neoplasms
Lymph Node Excision
Survival Rate
Hysterectomy
Survival
Ovariectomy
Lymph Nodes
Neoplasms
Therapeutics

Keywords

  • Endometrial cancer
  • Lymphadenectomy
  • Staging
  • Total abdominal hysterectomy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Role of pelvic lymphadenectomy in the management of Stage I endometrial cancer : Our experience. / Vizza, E.; Galati, G. M.; Corrado, G.; Sbiroli, C.

In: European Journal of Gynaecological Oncology, Vol. 24, No. 2, 2003, p. 126-128.

Research output: Contribution to journalArticle

@article{de678ddaa007487785e694412991f617,
title = "Role of pelvic lymphadenectomy in the management of Stage I endometrial cancer: Our experience",
abstract = "Objectives: To estimate the prognostic value of pelvic-node removal on survival of patients affected by endometrial carcinoma at presurgical FIGO Stage I. Methods: A retrospective analysis was performed on a total of 111 patients recruited from 1990 to 1996 at the S. Carlo di Nancy Hospital. Thirty-nine (35{\%}) of them underwent a total hysterectomy and bilateral salpingo-oophorectomy with removal of the vaginal cuff (group 1), while 72 (65{\%}) underwent a total hysterectomy combined with pelvic lymphadenectomy (group 2). Prognostic features including tumor grade, depth of myometrial invasion and histologic subtype. Survival rates were calculated with Cox and Kaplan analyses. Results: Overall survival rate at five years was 91.2{\%}. The survival rate of group 1 and group 2 was 89{\%} and 92.8{\%}, respectively which is not statistically significant. Stage, grade, histotype, age at diagnosis, and presence of positive lymph nodes did not show any significant prognostic value on survival probability. Conclusions: The survival rate for patients submitted to lymphadenectomy (group 2) was the same of patients who did not undergo this treatment (group 1). Nevertheless, pelvic lymphadenectomy in endometrial carcinoma at presurgical FIGO stage I was worthwhile as it allowed correct staging to be performed. The prediction of nodal disease based only on preoperative investigations (such as TC, NMR) is often inaccurate.",
keywords = "Endometrial cancer, Lymphadenectomy, Staging, Total abdominal hysterectomy",
author = "E. Vizza and Galati, {G. M.} and G. Corrado and C. Sbiroli",
year = "2003",
language = "English",
volume = "24",
pages = "126--128",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "2",

}

TY - JOUR

T1 - Role of pelvic lymphadenectomy in the management of Stage I endometrial cancer

T2 - Our experience

AU - Vizza, E.

AU - Galati, G. M.

AU - Corrado, G.

AU - Sbiroli, C.

PY - 2003

Y1 - 2003

N2 - Objectives: To estimate the prognostic value of pelvic-node removal on survival of patients affected by endometrial carcinoma at presurgical FIGO Stage I. Methods: A retrospective analysis was performed on a total of 111 patients recruited from 1990 to 1996 at the S. Carlo di Nancy Hospital. Thirty-nine (35%) of them underwent a total hysterectomy and bilateral salpingo-oophorectomy with removal of the vaginal cuff (group 1), while 72 (65%) underwent a total hysterectomy combined with pelvic lymphadenectomy (group 2). Prognostic features including tumor grade, depth of myometrial invasion and histologic subtype. Survival rates were calculated with Cox and Kaplan analyses. Results: Overall survival rate at five years was 91.2%. The survival rate of group 1 and group 2 was 89% and 92.8%, respectively which is not statistically significant. Stage, grade, histotype, age at diagnosis, and presence of positive lymph nodes did not show any significant prognostic value on survival probability. Conclusions: The survival rate for patients submitted to lymphadenectomy (group 2) was the same of patients who did not undergo this treatment (group 1). Nevertheless, pelvic lymphadenectomy in endometrial carcinoma at presurgical FIGO stage I was worthwhile as it allowed correct staging to be performed. The prediction of nodal disease based only on preoperative investigations (such as TC, NMR) is often inaccurate.

AB - Objectives: To estimate the prognostic value of pelvic-node removal on survival of patients affected by endometrial carcinoma at presurgical FIGO Stage I. Methods: A retrospective analysis was performed on a total of 111 patients recruited from 1990 to 1996 at the S. Carlo di Nancy Hospital. Thirty-nine (35%) of them underwent a total hysterectomy and bilateral salpingo-oophorectomy with removal of the vaginal cuff (group 1), while 72 (65%) underwent a total hysterectomy combined with pelvic lymphadenectomy (group 2). Prognostic features including tumor grade, depth of myometrial invasion and histologic subtype. Survival rates were calculated with Cox and Kaplan analyses. Results: Overall survival rate at five years was 91.2%. The survival rate of group 1 and group 2 was 89% and 92.8%, respectively which is not statistically significant. Stage, grade, histotype, age at diagnosis, and presence of positive lymph nodes did not show any significant prognostic value on survival probability. Conclusions: The survival rate for patients submitted to lymphadenectomy (group 2) was the same of patients who did not undergo this treatment (group 1). Nevertheless, pelvic lymphadenectomy in endometrial carcinoma at presurgical FIGO stage I was worthwhile as it allowed correct staging to be performed. The prediction of nodal disease based only on preoperative investigations (such as TC, NMR) is often inaccurate.

KW - Endometrial cancer

KW - Lymphadenectomy

KW - Staging

KW - Total abdominal hysterectomy

UR - http://www.scopus.com/inward/record.url?scp=0037248216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037248216&partnerID=8YFLogxK

M3 - Article

C2 - 12701960

AN - SCOPUS:0037248216

VL - 24

SP - 126

EP - 128

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 2

ER -